# Nuo Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jun 3, 2026

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: SCHEDULE 13D/A
- Filed: 2026-06-03
- Accepted by EDGAR: Jun 3, 2026, 15:04 ET
- Period: not reported
- Accession: 0001674752-26-000002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000167475226000002/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000167475226000002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000167475226000002/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jun 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001674752-26-000002. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.